Hepatology
Scientists find a way to cure hepatitis C with six weeks of treatment

Scientists find a way to cure hepatitis C with six weeks of treatment

Barcelona (Spain): A pilot study has found that all patients with acute HCV who were treated with a direct-acting antiviral treatment over a ‘short-duration’ of six weeks had undetectable HCV after a 12 week follow-up. more

New triple drug combination shows promise in hepatitis C infected patients

New triple drug combination shows promise in hepatitis C infected patients

Barcelona (Spain): New data presented on Thursday at The International Liver Congress 2016 in Barcelona, Spain, demonstrates a high sustained virologic response (SVR) at 12 weeks from the all-oral combination of sofosbuvir/velpatasvir and experimental compound GS-9857 in patients with the Hepatitis C virus (HCV). more

Chinese scientists develop liver tissue for transplants, drug screening

Chinese scientists develop liver tissue for transplants, drug screening

Beijing: Chinese researchers have engineered a liver tissue in the lab which closely mimics the organ’s complicated functions more effectively — a finding that can lead to the development of functional liver tissue for clinical applications and drug screening. more

Novel therapy could cut hepatitis C prevalence by 80 percent

Novel therapy could cut hepatitis C prevalence by 80 percent

New York: Recently approved antiviral medications for hepatitis C could reduce the prevalence of the blood-borne infection by more than 80 percent, researchers have estimated. more

Drug checks passage of hepatitis B virus during pregnancy

Drug checks passage of hepatitis B virus during pregnancy

Washington (IANS): The antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus (HBV), a new study says. more

Antibody prevents hepatitis C infection in animal model

Antibody prevents hepatitis C infection in animal model

Washington: A monoclonal antibody developed by MassBiologics of the University of Massachusetts Medical School (UMMS) and tested in an animal model at the Texas Biomedical Research Institute prevents infection by the hepatitis C virus (HCV). more

Researchers develop new approach to treat acute liver failure

Researchers develop new approach to treat acute liver failure

Berlin: Acute liver failure is a life-threatening disease, characterized by a sudden, massive death of liver cells. Unfortunately, few treatment options exist, especially for advanced-stage liver failure. As a last resort a liver transplant may be the only remaining option. Now Dr Junfeng An, a physician of the Max Delbruck Centre for Molecular Medicine (MDC) Berlin-Buch and Dr Stefan Donath, a specialist in internal medicine and cardiology, also of the MDC and Helios Klinikum Berlin-Buch, have developed a new treatment approach based on a mouse model. more

‘Pregnant women more vulnerable to Hepatitis E-induced liver failure’

‘Pregnant women more vulnerable to Hepatitis E-induced liver failure’

New Delhi: In one of the widest single-centre studies conducted by the All India Institute of Medical Sciences (AIIMS) here, it was found that water-borne Hepatitis E was the basic cause of acute liver failure in nearly 60 per cent of pregnant women. more

New animal model may lead to treatments for common liver disease

New animal model may lead to treatments for common liver disease

Washington: Scientists at Texas Biomed have developed the laboratory opossum as a new animal model to study the most common liver disease in the nation – afflicting up to 15 million Americans – and for which there is no cure. more

Boosting cell production could help treat liver disease

Boosting cell production could help treat liver disease

London: The University of Edinburgh scientists have shed light on how the liver repairs itself with research that could help develop drugs to treat liver disease. more